Prescient Therapeutics Ltd (ASX:PTX)
A$ 0.041 0 (0%) Market Cap: 33.02 Mil Enterprise Value: 18.84 Mil PE Ratio: 0 PB Ratio: 1.86 GF Score: 0/100

Prescient Therapeutics Ltd Investor Presentation Transcript

Sep 27, 2022 / 02:00AM GMT
Release Date Price: A$0.18
Patrick Nelson
Reach Markets Pvt Ltd - Moderator

Presentation
Sep 27, 2022 / 02:00AM GMT

=====================
Corporate Participants
=====================
* Steven Yatomi-Clarke
Prescient Therapeutics Limited - CEO, MD
* Rebecca Lim
Prescient Therapeutics Limited - Senior VP, Scientific Affairs

=====================
Conference Call Participants
=====================
* Patrick Nelson
Reach Markets Pvt Ltd - Moderator

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot